OTC Pharmaceuticals - Mexico

  • Mexico
  • Revenue in the OTC Pharmaceuticals market amounts to US$2,132.00m in 2024. The market is expected to grow annually by 3.65% (CAGR 2024-2029).
  • The market's largest segment is the segment Cold & Cough Remedies with a market volume of US$446.30m in 2024.
  • In global comparison, most revenue is generated in the United States (US$41,240m in 2024).
  • In relation to total population figures, per person revenues of US$16.48 are generated in 2024.
  • In the OTC Pharmaceuticals market, 31.6% of total revenue will be generated through online sales by 2024.

Key regions: Worldwide, India, Philippines, United States, Europe

Region comparison

Analyst Opinion

The OTC Pharmaceuticals market in Mexico is experiencing significant growth and development.

Customer preferences:
Mexican consumers are increasingly turning to over-the-counter (OTC) pharmaceutical products for their healthcare needs. This shift in consumer behavior can be attributed to several factors. Firstly, the rising healthcare costs and limited access to healthcare services in Mexico have led consumers to seek more affordable and convenient alternatives. OTC medications provide a cost-effective solution for minor ailments and common health issues. Secondly, there is a growing awareness and acceptance of self-medication among Mexican consumers. They are becoming more proactive in managing their health and are willing to try OTC products for self-treatable conditions. Finally, the availability and accessibility of OTC medications in various retail channels, including pharmacies, supermarkets, and online platforms, have made it easier for consumers to purchase these products.

Trends in the market:
One of the key trends in the OTC Pharmaceuticals market in Mexico is the increasing demand for natural and herbal remedies. Mexican consumers are showing a preference for products that are perceived to be more natural and have fewer side effects. This trend is driven by a growing interest in alternative medicine and a desire for holistic approaches to health and wellness. As a result, manufacturers are introducing a wider range of natural and herbal OTC products to cater to this demand. Another trend in the market is the focus on preventive healthcare. Mexican consumers are becoming more health-conscious and are taking proactive measures to prevent illnesses and maintain their well-being. This has led to an increased demand for OTC products such as vitamins, dietary supplements, and preventive medications. Manufacturers are responding to this trend by launching innovative products that target specific health concerns and offer preventive benefits.

Local special circumstances:
Mexico has a large and growing population, which presents a significant market opportunity for OTC Pharmaceuticals. The country's demographics, with a large proportion of young and middle-aged individuals, contribute to the demand for OTC products. Additionally, Mexico has a relatively high prevalence of chronic diseases such as diabetes and hypertension, which further drives the demand for OTC medications to manage these conditions. The regulatory environment in Mexico also plays a role in shaping the OTC Pharmaceuticals market. The country has a well-established regulatory framework that ensures the safety, efficacy, and quality of OTC products. This gives consumers confidence in purchasing and using these products. However, the regulatory landscape can also pose challenges for manufacturers, particularly in terms of product registration and compliance with labeling requirements.

Underlying macroeconomic factors:
Several macroeconomic factors contribute to the development of the OTC Pharmaceuticals market in Mexico. The country's economic growth and increasing disposable income levels have enabled consumers to spend more on healthcare products, including OTC medications. Additionally, the urbanization and modernization of Mexico have led to changes in lifestyle and healthcare patterns, creating opportunities for OTC products. Furthermore, the COVID-19 pandemic has had a significant impact on the OTC Pharmaceuticals market in Mexico. The outbreak has heightened awareness about health and hygiene, leading to increased demand for OTC products such as hand sanitizers, disinfectants, and immune-boosting supplements. The pandemic has also accelerated the adoption of e-commerce and online retail channels, providing consumers with convenient access to OTC medications. In conclusion, the OTC Pharmaceuticals market in Mexico is witnessing growth and development driven by changing consumer preferences, including a preference for natural and preventive healthcare solutions. The country's large population, regulatory environment, and underlying macroeconomic factors also contribute to the market's expansion.


Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.


In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.


  • Revenue
  • Key Players
  • Analyst Opinion
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait


Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)